A new finding just released on Pubmed presented a study recently performed in London providing preliminary evidence for whether cannabis can be used to treat patients with ADHD, potentially opening the door for a new way to treat adults and kids. This was a controlled study done on a small group of 30 adults formerly diagnosed with ADHD who were treated using a product called Sativex. Sativex is an oromucosal spray, the name referring to its anti-inflammatory agents.
This product was developed through the extraction of THC and CBD from the cannabis plant. The group of 30 testees were to medicate and then perform the QBtech test. The QBtech test is an FDA approved test “for use as an aid in the assessment and treatment evaluation of ADHD for people aged 6 to 60 years old.” The results given by this study indicated significant improvement on patients “attention..activity and cognitive performance, and emotional lability.” The patients from this study expressed a profound preference of medicating using cannabis over traditional ADHD medication.
READ THE FULL ARTICLE BELOW